These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10671192)

  • 1. Different doses of agonistic ligand drive the maturation of functional CD4 and CD8 T cells from immature precursors.
    Lovatt M; Yang TH; Stauss HJ; Fisher AG; Merkenschlager M
    Eur J Immunol; 2000 Feb; 30(2):371-81. PubMed ID: 10671192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
    Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
    Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the thymic environment on the CD4-versus-CD8 T lineage decision.
    Canelles M; Park ML; Schwartz OM; Fowlkes BJ
    Nat Immunol; 2003 Aug; 4(8):756-64. PubMed ID: 12858172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specialisation of thymic epithelial cells for positive selection of CD4+8+ thymocytes.
    Hare KJ; Jenkinson EJ; Anderson G
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):119-27. PubMed ID: 11292246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-mediated presentation of MHC class II molecules guides thymocytes to the CD4 lineage.
    Komaniwa S; Hayashi H; Kawamoto H; Sato SB; Ikawa T; Katsura Y; Udaka K
    Eur J Immunol; 2009 Jan; 39(1):96-112. PubMed ID: 19089815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD8 alpha' in the CD4 versus CD8 lineage choice.
    Salmon P; Mong M; Kang XJ; Cado D; Robey E
    J Immunol; 1999 Nov; 163(10):5312-8. PubMed ID: 10553054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes "paradoxically" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells.
    Bosselut R; Guinter TI; Sharrow SO; Singer A
    J Exp Med; 2003 Jun; 197(12):1709-19. PubMed ID: 12810689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells.
    Van Coppernolle S; Verstichel G; Timmermans F; Velghe I; Vermijlen D; De Smedt M; Leclercq G; Plum J; Taghon T; Vandekerckhove B; Kerre T
    J Immunol; 2009 Oct; 183(8):4859-70. PubMed ID: 19801512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor signals and nuclear events in CD4 and CD8 T cell lineage commitment.
    Laky K; Fowlkes BJ
    Curr Opin Immunol; 2005 Apr; 17(2):116-21. PubMed ID: 15766669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase subunit G5PR that regulates the JNK-mediated apoptosis signal is essential for the survival of CD4 and CD8 double-positive thymocytes.
    Xing Y; Wang X; Igarashi H; Kawamoto H; Sakaguchi N
    Mol Immunol; 2008 Apr; 45(7):2028-37. PubMed ID: 18022237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular and molecular mechanism of CD4/CD8 lineage commitment.
    Yasutomo K
    J Med Invest; 2002 Feb; 49(1-2):1-6. PubMed ID: 11901754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antagonist peptide mediates positive selection and CD4 lineage commitment of MHC class II-restricted T cells in the absence of CD4.
    Kao H; Allen PM
    J Exp Med; 2005 Jan; 201(1):149-58. PubMed ID: 15630142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision.
    Sato T; Chiba T; Ohno S; Sato C; Sugoh T; Miyashita K; Akatsuka H; Hozumi K; Okada Y; Iida Y; Akatsuka A; Agata Y; Chiba M; Kohu K; Satake M; Tanabe H; Saya H; Habu S
    J Immunol; 2012 Nov; 189(9):4426-36. PubMed ID: 23018457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage-specific requirement for the PH domain of Vav1 in the activation of CD4+ but not CD8+ T cells.
    Prisco A; Vanes L; Ruf S; Trigueros C; Tybulewicz VL
    Immunity; 2005 Sep; 23(3):263-74. PubMed ID: 16169499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.
    He X; He X; Dave VP; Zhang Y; Hua X; Nicolas E; Xu W; Roe BA; Kappes DJ
    Nature; 2005 Feb; 433(7028):826-33. PubMed ID: 15729333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for sustained MAPK signaling in both CD4 and CD8 lineage commitment: a threshold model.
    Wilkinson B; Kaye J
    Cell Immunol; 2001 Aug; 211(2):86-95. PubMed ID: 11591112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA3 controls the expression of CD5 and the T cell receptor during CD4 T cell lineage development.
    Ling KW; van Hamburg JP; de Bruijn MJ; Kurek D; Dingjan GM; Hendriks RW
    Eur J Immunol; 2007 Apr; 37(4):1043-52. PubMed ID: 17357106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR and Notch signaling in CD4 and CD8 T-cell development.
    Laky K; Fleischacker C; Fowlkes BJ
    Immunol Rev; 2006 Feb; 209():274-83. PubMed ID: 16448548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus.
    He X; Park K; Wang H; He X; Zhang Y; Hua X; Li Y; Kappes DJ
    Immunity; 2008 Mar; 28(3):346-58. PubMed ID: 18342007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive selection of T cells, an in vitro view.
    Dervović D; Zúñiga-Pflücker JC
    Semin Immunol; 2010 Oct; 22(5):276-86. PubMed ID: 20537907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.